148 related articles for article (PubMed ID: 26889610)
21. Pharmacogenetics of pain management in Zimbabwean patients with sickle cell disease.
Mapira NL; Thelingwani RS; Chikwambi Z; Kuona P; Masimirembwa C
Pharmacogenomics; 2023 May; 24(7):359-369. PubMed ID: 37248824
[No Abstract] [Full Text] [Related]
22. Pharmacogenetics of opioid response.
Somogyi AA; Coller JK; Barratt DT
Clin Pharmacol Ther; 2015 Feb; 97(2):125-7. PubMed ID: 25670515
[TBL] [Abstract][Full Text] [Related]
23. [Interindividual variation of pharmacokinetic disposition of and clinical responses to opioid analgesics in cancer pain patients].
Naito T; Kawakami J
Yakugaku Zasshi; 2015; 135(5):709-15. PubMed ID: 25948306
[TBL] [Abstract][Full Text] [Related]
24. The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone.
Boswell MV; Stauble ME; Loyd GE; Langman L; Ramey-Hartung B; Baumgartner RN; Tucker WW; Jortani SA
Pain Physician; 2013; 16(3):E227-35. PubMed ID: 23703421
[TBL] [Abstract][Full Text] [Related]
25. Suspected opioid overdose case resolved by CYP2D6 genotyping.
Shaw KD; Amstutz U; Jimenez-Mendez R; Ross CJ; Carleton BC
Ther Drug Monit; 2012 Apr; 34(2):121-3. PubMed ID: 22406651
[TBL] [Abstract][Full Text] [Related]
26. Fatal hydrocodone overdose in a child: pharmacogenetics and drug interactions.
Madadi P; Hildebrandt D; Gong IY; Schwarz UI; Ciszkowski C; Ross CJ; Sistonen J; Carleton BC; Hayden MR; Lauwers AE; Koren G
Pediatrics; 2010 Oct; 126(4):e986-9. PubMed ID: 20837591
[TBL] [Abstract][Full Text] [Related]
27. Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectives.
Lötsch J; Skarke C; Liefhold J; Geisslinger G
Clin Pharmacokinet; 2004; 43(14):983-1013. PubMed ID: 15530129
[TBL] [Abstract][Full Text] [Related]
28. Effect of cigarette smoking on serum hydrocodone levels in chronic pain patients.
Ackerman WE; Ahmad M
J Ark Med Soc; 2007 Jul; 104(1):19-21. PubMed ID: 17663288
[TBL] [Abstract][Full Text] [Related]
29. CYP2D6 pharmacogenetic and oxycodone pharmacokinetic association study in pediatric surgical patients.
Balyan R; Mecoli M; Venkatasubramanian R; Chidambaran V; Kamos N; Clay S; Moore DL; Mavi J; Glover CD; Szmuk P; Vinks A; Sadhasivam S
Pharmacogenomics; 2017 Mar; 18(4):337-348. PubMed ID: 28244808
[TBL] [Abstract][Full Text] [Related]
30. Endogenous and iatrogenic sources of variability in response to opioid therapy in Post-Surgical and injured orthopedic patients.
Langman LJ; Gaskins J; Korte E; Maluf C; Wooderchak-Donahue WL; McMillin GA; Jannetto PJ; Hartley B; Malkani A; Yakkanti M; Jortani SA
Clin Chim Acta; 2021 Nov; 522():105-113. PubMed ID: 34384754
[TBL] [Abstract][Full Text] [Related]
31. Leveraging precision medicine to mitigate medication-safety challenges.
Gammal RS; Hoffman JM
Am J Health Syst Pharm; 2017 Dec; 74(24):2031-2032. PubMed ID: 29222358
[No Abstract] [Full Text] [Related]
32. [Genetic polymorphisms and human sensitivity to pain and opioids].
Nishizawa D; Nagashima M; Satoh Y; Tagami M; Ikeda K
Masui; 2009 Sep; 58(9):1093-101. PubMed ID: 19764431
[TBL] [Abstract][Full Text] [Related]
33. Hydrocodone in postoperative personalized pain management: pro-drug or drug?
Stauble ME; Moore AW; Langman LJ; Boswell MV; Baumgartner R; McGee S; Metry J; Jortani SA
Clin Chim Acta; 2014 Feb; 429():26-9. PubMed ID: 24269714
[TBL] [Abstract][Full Text] [Related]
34. Evidence Regarding Pharmacogenetics in Pain Management and Cancer.
Smith DM; Figg WD
Oncologist; 2023 Mar; 28(3):189-192. PubMed ID: 36718020
[TBL] [Abstract][Full Text] [Related]
35. Breast milk hydrocodone and hydromorphone levels in mothers using hydrocodone for postpartum pain.
Koren G
Obstet Gynecol; 2011 Jun; 117(6):1439. PubMed ID: 21606765
[No Abstract] [Full Text] [Related]
36. CYP2D6 in the metabolism of opioids for mild to moderate pain.
Leppert W
Pharmacology; 2011; 87(5-6):274-85. PubMed ID: 21494059
[TBL] [Abstract][Full Text] [Related]
37. Variability in the frequency of cytochrome P450-2D6 (CYP2D6) deficiency.
Mörike K; Platten HP; Mikus G; Klotz U
Br J Clin Pharmacol; 1998 Jul; 46(1):87. PubMed ID: 9690955
[No Abstract] [Full Text] [Related]
38. Pharmacogenomics and prescription opioid use.
Benjeddou M; Peiró AM
Pharmacogenomics; 2021 Mar; 22(4):235-245. PubMed ID: 33445954
[TBL] [Abstract][Full Text] [Related]
39. Gender difference in prescription opioid abuse: A focus on oxycodone and hydrocodone.
Graziani M; Nisticò R
Pharmacol Res; 2016 Jun; 108():31-38. PubMed ID: 27107788
[TBL] [Abstract][Full Text] [Related]
40. Hydrocodone bitartrate for chronic pain.
Manchikanti L; Atluri S; Kaye AM; Kaye AD
Drugs Today (Barc); 2015 Jul; 51(7):415-27. PubMed ID: 26261844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
